Clinical Trial Update: The OPTIMISE Study [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update announcing ongoing recruitment for the OPTIMISE study evaluating treatment for Pseudophakic Bullous Keratopathy and Fuchs' Endot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fuchs Endothelial Dystrophy
• Pseudophakic Bullous Keratopathy

Snippet

Sponsor: Maastricht University Medical Center | Conditions: Pseudophakic Bullous Keratopathy, Fuchs' Endothelial Dystrophy | Phase 4 | Status: RECRUITING